TWI223070B - Method of detecting virus in a test solution using a quartz crystal micro-balance - Google Patents
Method of detecting virus in a test solution using a quartz crystal micro-balance Download PDFInfo
- Publication number
- TWI223070B TWI223070B TW92127478A TW92127478A TWI223070B TW I223070 B TWI223070 B TW I223070B TW 92127478 A TW92127478 A TW 92127478A TW 92127478 A TW92127478 A TW 92127478A TW I223070 B TWI223070 B TW I223070B
- Authority
- TW
- Taiwan
- Prior art keywords
- quartz crystal
- value
- frequency
- virus
- test solution
- Prior art date
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
1223070 玖、發明說明: 【發明所屬之技術領域】 本發明涉及一種石英晶體微天平檢測病毒的方去,特 別是關於一種在試液中利用石英晶體微天平檢測病主的 方法。 骨 【先前技術】 現有技術中,對病毒的檢測方法有以下幾種· 1 ·分子測试(PCR)法:即直接檢定聚合酶連鎖反應的病 毒核酸基因體序列,因基因體序列長常達幾萬個,因此該1223070 发明 Description of the invention: [Technical field to which the invention belongs] The present invention relates to a quartz crystal microbalance for detecting viruses, and particularly to a method for detecting a patient using a quartz crystal microbalance in a test solution. Bone [Prior art] In the prior art, there are several methods for detecting viruses: 1. Molecular test (PCR) method: the direct detection of the sequence of the viral nucleic acid genome of a polymerase chain reaction. Tens of thousands, so this
方法檢定過程比較費時,而且成本很高,另外因為相類= 的病毒基因序列的重複較多,因而造成檢驗靈敏度差。 2·免疫螢光分析法(Immunoflu〇rescence心以幻:即利 用含有病毒抗體的血清中的抗體當作檢驗試劑和疑似病 患者的血清混合,若患者的血清含有病毒,將和檢驗試劑 的抗體結合,而改變檢驗試劑的螢光光譜。採用這種方法 檢定要等到有明顯光譜效應後才能得出測試結果,因而要 在患者病後多日才能測出,而且靈敏性與專—性不足。 3·細胞繁殖培養法:即將病人檢體分離出的病毒,加The method verification process is time-consuming and costly. In addition, because the virus gene sequence of the same type is more repetitive, the test sensitivity is poor. 2. Immunofluorescence analysis (Immunofluorescence): use antibodies in serum containing virus antibodies as test reagents and mix the serum of patients with suspected disease. Combining and changing the fluorescence spectrum of the test reagent. With this method, the test result can only be obtained after there is a significant spectral effect, so it can be measured several days after the patient is sick, and the sensitivity and specificity are insufficient. Cell proliferation culture method: the virus isolated from patient specimens, plus
以繁殖’這種方法僅能提供有活性病毒的證據,而且檢 過程較為費時。 4.石英晶體微天平舊方法:目前使用較在at切巧 石英晶片的電極探計上放上抗體,抗體與相對應的病毒結 二而產生微量質量的增加,然後用—π定律(舒博瑞 定律如下所不),测出頻率變化,由容易測出的頻率變 化而推出質量微量增加。 Δί=— 2f02 *] Διη 5 1223070 式中:△ f :頻率變化, △ m :質量變化, f〇 :石英晶體原有頻率, P q :石英密度,The method of reproduction 'can only provide evidence of a live virus, and the inspection process is time consuming. 4. The old method of quartz crystal microbalance: At present, the antibody is placed on the electrode probe of the quartz crystal chip at least, the antibody and the corresponding virus are combined to produce a trace mass increase, and then the -π law (Schubert's law is as follows No), the measured frequency change is derived from the easy-to-measure frequency change, which leads to a slight increase in mass. Δί = — 2f02 *] Διη 5 1223070 where: △ f: frequency change, △ m: mass change, f0: original frequency of quartz crystal, P q: quartz density,
Cq :石英變形係數; 加上固體質律量的1 用兄於=:或空氣中的石英晶體」 ^Th. v 真空蒸鍍時所用厚度監老 硬體薄Cq: coefficient of deformation of quartz; plus solid mass of 1 for use =: or quartz crystals in the air "^ Th. V Thickness used in vacuum evaporation for monitoring
=乎都是對試液如血液、唾液等二 毒試液進行檢測,是本發明要研究的_ 千對病 【發明内容】 針對上J«題’本發明的目的是提供_種能夠在試; 中利用石英晶體微天平檢測病毒的方法。 為實現上述目的,本發明採用以下技術方案:一= Almost all test liquids such as blood, saliva and other secondary toxic liquids are tested, which is what the present invention is to study _ Thousand Pairs of Disease [Summary of the Invention] The purpose of the present invention is to provide _ species that can be tested; Method for detecting virus using quartz crystal microbalance. To achieve the above objective, the present invention adopts the following technical solutions:
試液中利用石英晶體微天平檢_毒时法,其步驟如 下· ⑴在石英晶體微天平的探針上黏附與預檢測病毒對 應的抗體,乾燥後’測量石英晶體在真空或空氣中的頻率 值f〇 ’並將其作為基準值; (2)將經步驟⑴處理的探針放人沒有病毒,但鱼待測試 液相同的溶液中,測量溶液中無病毒情況下石英晶體的頻 率值h,計算出頻率值㈣基準值f〇之間的變化值 fl-f〇 ; 6 1223070 (3) 將經步驟(1)處理的探針放入待測試液中,測量在試 液中石英晶體的頻率值fm,計算出頻率值fm與基準值 之間的變化值△ fm= fm-f〇 ; (4) 比較步驟(2)和步驟(3)的頻率變化值,如果二者數 值相等,說明試液中沒有病毒;如果△^與^ fl數值不同,丨△fmj >| Afi丨則證明試液中有病毒存 在。 ,中步驟(2)計算出的頻率變化值△ fi應符合 定律(卡納甘互定律):Quartz crystal microbalance is used in the test solution to test the toxic time. The steps are as follows: ⑴ Adhere the antibody corresponding to the pre-detected virus to the probe of the quartz crystal microbalance, and dry it to measure the frequency of the quartz crystal in vacuum or air. f〇 'and use it as a reference value; (2) Put the probe treated in step 人 into a human without virus, but in the same solution as the fish to be tested, and measure the frequency h of the quartz crystal in the absence of virus in the solution. Calculate the change between the frequency value and the reference value f f; 6 1223070 (3) Put the probe processed in step (1) into the test solution, and measure the frequency of the quartz crystal in the test solution fm, calculate the change between the frequency value fm and the reference value △ fm = fm-f〇; (4) Compare the frequency change values of step (2) and step (3), if the two values are equal, the test solution No virus; if △ ^ and ^ fl have different values, △△ fmj > | Afi 丨 proves that there is virus in the test solution. The frequency change value △ fi calculated in step (2) should conform to the law (Kanagan's mutual law):
…[一 厂] ^qCq V 风 式中·△ fl ·石央晶體放入溶液中產生頻率變化量, f〇 :石英晶體原有頻率, P q :石英晶體密度,… [One plant] ^ qCq V wind type · △ fl · Shiyang crystal puts in the solution to produce the frequency change amount, f0: original frequency of quartz crystal, P q: density of quartz crystal,
Cq ·石英變形係數, P 1 :液體密度, π 1 :液體黏滯度。Cq · Quartz deformation coefficient, P 1: liquid density, π 1: liquid viscosity.
其中步驟(3)計算出的頻率變化值Aim應符合Martin 定律(馬丁定律): 2f〇2The frequency change value Aim calculated in step (3) should conform to Martin's law (Martin's law): 2f〇2
[P[P
Pi Πι 式中 • Δίπι ··溶液中厚度質量改變的頻率變化量 fo ··石英晶體原有頻率, 7 1223070 q :石英晶體密度,Pi Πι where: Δίπι ·· frequency change of thickness and mass change in solution fo ·· the original frequency of quartz crystal, 7 1223070 q: density of quartz crystal,
Cq ·石英變形係數,Cq · quartz deformation coefficient,
Ps·增加表面厚度質量層的單位面積密度, P 1 :液體密度, β 1 :液體黏滯度。 在比較步驟(2)和步驟(3)的頻率變化值時,如果石英 晶體在試液中的頻率變化符合Kanazawa定律,即 證明試液中沒有病毒,如果石英晶體在試液中的頻率 變化符合Martin定律,即丨μ丨 >丨_,證明試液 :有病毒存在,且可以通過Martin定律計算出石英晶體 微天平探針上病毒的抗體與抗原結合增加的微量質量。 可以在所述石英晶體微天平上設置複數個石英晶體 陣列,在每一所述陣列上設置一電極探針,在每一所述探Ps · Density per unit area of the mass layer with increased surface thickness, P 1: liquid density, β 1: liquid viscosity. When comparing the frequency change values of step (2) and step (3), if the frequency change of the quartz crystal in the test solution conforms to Kanazawa's law, it is proved that there is no virus in the test solution. If the frequency change of the quartz crystal in the test solution conforms to Martin's law, That is, 丨 μ 丨 > 丨 _, it proves that the test solution: virus exists, and the micro mass of the virus antibody and antigen binding on the quartz crystal microbalance probe can be calculated by Martin's law. A plurality of quartz crystal arrays may be provided on the quartz crystal microbalance, an electrode probe is provided on each of the arrays, and
針上黏附上不同病毒的相應抗體,在同時檢測待測 的多種病毒。 T 本發明由於採取以上技術方案,其具有以下優點: 主二1、本發明方法利用在石英晶體微天平探針上黏附病 ,抗體,與待測試液中的病毒抗原相結合的原理,通過測 :石英晶體在空氣或真空中的頻率,測量石英晶體在無病 毒溶液中的頻率變化,以及測量石英晶體在待測試液;的 頻率變化,並將頻率變化加以比較,實現了石英晶體微天 平在液體中檢測病毒的目的。 2、本發明引入Kanazawa定律和Martin定律,不但 了以彳于到有無病毒的結論,而且可以精確地測量出病毒 量,其靈敏度可達到< 1 〇·8克。 货 8 1223070 3、本發明不但提出了在液體中使用石英晶體微天平 · 測量病毒的方法,而且本方法與已有測量方法相比,檢測 . 方便,出結果快,檢測成本低,特別是在石英晶體微天平 上設置複數個石英晶體列陣,在不同石英晶體探針上黏附 與不同病毒相對應的單株抗體,可以一次同時檢測出待测 試液中的多種微量病毒,也可檢測出重複交叉感染。這是 目前世界上最敏感的檢測試液中有無病毒的方法。本發明 方法可以廣泛地應用於各種液體試樣的病毒檢測中。 【實施方式】 本案將藉由下列實施例說明,以更詳盡描述本案之 春 技術特徵,並益加確認本案之獨特性及可行性。 實施例一:檢測泡疹病毒(human herpes Viruses) 石英晶體微天平使用AT切割圓形石英晶體晶片,直 徑8.0mm,圓形金屬電極直徑4.〇mm,厚度2〇〇nm,平面 基本波,10MHz石英晶體探針,先浸泡入CMV65_kDe抗 體溶液中,使單層CMV65-kDe抗體黏附在石英晶體探針 表面上,待乾燥後,測量石英晶體的原始頻率f(),再將探 籲 針放入;又有病毋,但與待測试液相同的溶液中,測量溶液 中無病毒情況下石英晶體的頻率值fl,相據Kanazawas 律,可知頻率值A降低,頻率值匕與基準值4之間的變 化值△[= 。 將此黏附有CMV65-kDe抗體的石英晶體探針,浸入 可能含有泡疹病毒的試液中,此時如有泡疹病毒存在,則 - 抗體將與泡疹病毒的抗原相結合,使石英晶體探針的表面 9 1223070 厚度(質量)增加,其符合Martin定律,石英晶體的頻率進 · 一步降低,即| Aiml >丨Afil ,則可以檢測出試液中 有泡療病毒存在,完成檢驗。 如測量出的石英晶體頻率變化值△ fm=Z\ fi,符合 Kanazawa定律,則表明待測試液中無泡療病毒存在,完 成檢驗。 實施例二:檢測免疫缺陷病毒(antihuman immuodefficiency viruses, HIV) 石英晶體微天平使用AT切割圓形石英晶體晶片,直 籲 徑8.0mm,圓形金屬電極直徑4.0mm,厚度200nm,平面 基本波,10MHz石英晶體探針,先浸泡入anti-HIV manoclonel抗體溶液中,使單層anti_HIV manoclonel抗體 黏附在石英晶體探針表面上,待乾燥後,測量石英晶體的 原始頻率fG,再將探針放入沒有病毒,但與待測試液相同 的溶液中,測量此時石英晶體的頻率值fi,相據Kanazawa 定律,可知頻率值f i降低,頻率值f i與基準值fG之間的 變化值 fl-f〇。 將此黏附有anti-HIV manoclonel抗體的石英晶體探 鲁 針,浸入可能含有免疫病毒的試液中,此時如有免疫病毒 存在,則抗體將與免疫病毒的抗原相結合,使石英晶體探 針的表面厚度質量增加,其符合Martin定律,頻率進一 步降低,即| Aiml >丨Δί\| ,則可以檢測出試液中有 免疫病毒存在,完成檢驗。 如測量出的石英晶體頻率變化值,符合 Kanazawa定律,則表明待測試液中無免疫缺陷病毒存 10 1223070 在,完成檢驗 實施例三:同時檢測不同的病毒 複數個石英曰央;體楗天平應用電腦可以同時排列及使用 探針,且在不同的石英晶體探 不同病毋的相應單株抗體, Π1 4+^ 了以同時讀出各個石英晶體探 體曰片上广括各:施例中’石英晶體微天平所使用的石英晶 體曰日片包括各種切刻古斗 穴曰曰Corresponding antibodies of different viruses are attached to the needles to detect multiple viruses at the same time. T The present invention has the following advantages due to the adoption of the above technical solutions: 1. The method of the present invention uses the principle of combining disease, antibody on the quartz crystal microbalance probe with the virus antigen in the test solution, and : The frequency of quartz crystal in air or vacuum, measuring the frequency change of quartz crystal in virus-free solution, and measuring the frequency change of quartz crystal in the liquid to be tested; and comparing the frequency change to achieve the quartz crystal microbalance in Purpose of detecting virus in liquid. 2. The present invention introduces Kanazawa's law and Martin's law, which not only draws conclusions about the presence or absence of virus, but also can accurately measure the amount of virus, and its sensitivity can reach <10.8 g. Goods 8 1223070 3. The present invention not only proposes a method for measuring a virus using a quartz crystal microbalance in a liquid, but also the method can detect compared with the existing measurement methods. Convenient, fast results, low detection cost, especially in A plurality of quartz crystal arrays are set on the quartz crystal microbalance, and the individual antibodies corresponding to different viruses are adhered to different quartz crystal probes, which can simultaneously detect multiple trace viruses in the test solution at the same time, and can also detect duplicates. cross-infection. This is currently the world's most sensitive method for detecting virus in test solutions. The method of the invention can be widely applied to the virus detection of various liquid samples. [Embodiment] This case will be described by the following examples to describe the spring technical features of this case in more detail, and to confirm the uniqueness and feasibility of this case. Example 1: Detection of herpes virus (human herpes Viruses) quartz crystal microbalance using AT cut circular quartz crystal wafer, diameter 8.0mm, circular metal electrode diameter 4.0mm, thickness 200nm, plane fundamental wave, 10MHz quartz crystal probe, first immersed in CMV65_kDe antibody solution, so that a single layer of CMV65-kDe antibody adheres to the surface of the quartz crystal probe, after drying, measure the original frequency f () of the quartz crystal, and then put the probe needle There is no disease, but in the same solution as the test solution, measure the frequency value of the quartz crystal in the absence of virus in the solution. According to Kanazawas' law, it can be seen that the frequency value A is reduced, and the frequency value is equal to the reference value 4 The change value between △ [=. Immerse this quartz crystal probe with CMV65-kDe antibody in a test solution that may contain herpes virus. At this time, if herpes virus is present, the antibody will combine with the antigen of herpes virus to detect the quartz crystal. Needle surface 9 1223070 The thickness (mass) increases, which conforms to Martin's law, and the frequency of quartz crystals is further reduced, that is, | Aiml > 丨 Afil, you can detect the presence of effervescent virus in the test solution, and complete the test. If the measured value of the frequency change of the quartz crystal △ fm = Z \ fi is in accordance with Kanazawa's law, it means that there is no effervescent virus in the test solution, and the inspection is completed. Example 2: Detecting antihuman immuodefficiency viruses (HIV) Quartz crystal microbalance uses AT to cut a round quartz crystal wafer, with a diameter of 8.0mm, a diameter of a circular metal electrode of 4.0mm, a thickness of 200nm, a plane fundamental wave, 10MHz Quartz crystal probe, first immersed in anti-HIV manoclonel antibody solution, so that a single layer of anti_HIV manoclonel antibody adheres to the surface of the quartz crystal probe, after drying, measure the original frequency fG of the quartz crystal, and then put the probe into Virus, but in the same solution as the test solution, measure the frequency value fi of the quartz crystal at this time. According to Kanazawa's law, it can be seen that the frequency value fi decreases, and the change value between the frequency value fi and the reference value fG is fl-f0. The quartz crystal probe with the anti-HIV manoclonel antibody attached is immersed in a test solution that may contain an immune virus. At this time, if the immune virus is present, the antibody will be combined with the antigen of the immune virus to make the quartz crystal probe As the thickness of the surface increases, it conforms to Martin's law, and the frequency is further reduced, that is, | Aiml > 丨 Δί \ |, then the presence of immune virus in the test solution can be detected, and the test can be completed. If the measured frequency change of the quartz crystal is in accordance with Kanazawa's law, it indicates that there is no immunodeficiency virus in the test solution. 10 1223070 The test is completed. Example 3: Simultaneous detection of multiple viruses with multiple quartz cells; The computer can arrange and use the probes at the same time, and detect the corresponding individual antibodies of different diseases in different quartz crystals. Π1 4 + ^ to read out each quartz crystal body at the same time. Quartz crystals used in crystal microbalances include various incisions
等切割方式式’如at、bt、ct、dt、fc、 天平檢測病斤-述的方本:提供一種在試液中利用石英晶體微 病毒的方法:能用二用以解決習知石英晶體微天平檢測 檢測的準確性、b縮短二:::體物質的缺點,並可有效增加 =逑之實施例詳細敘述而可由熟悉本技藝之人士2 二了而為顿修飾’㈣残如㈣請專利範圍所欲保護And other cutting methods, such as at, bt, ct, dt, fc, and scales to detect disease weight-the formula described above: to provide a method to use quartz crystal microvirus in the test solution: two can be used to solve the conventional quartz crystal micro Accuracy of balance detection, shortening of B 2 ::: shortcomings of body substances, and can effectively increase = 逑 The examples are described in detail and can be modified by those familiar with the art 2 顿 and modified for the sake of ㈣㈣ 如 ㈣ Scope protection
11 1223070 【圖式簡單說明】11 1223070 [Schematic description]
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW92127478A TWI223070B (en) | 2003-10-03 | 2003-10-03 | Method of detecting virus in a test solution using a quartz crystal micro-balance |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW92127478A TWI223070B (en) | 2003-10-03 | 2003-10-03 | Method of detecting virus in a test solution using a quartz crystal micro-balance |
Publications (2)
Publication Number | Publication Date |
---|---|
TWI223070B true TWI223070B (en) | 2004-11-01 |
TW200513648A TW200513648A (en) | 2005-04-16 |
Family
ID=34546329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW92127478A TWI223070B (en) | 2003-10-03 | 2003-10-03 | Method of detecting virus in a test solution using a quartz crystal micro-balance |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI223070B (en) |
-
2003
- 2003-10-03 TW TW92127478A patent/TWI223070B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TW200513648A (en) | 2005-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lifson et al. | Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring | |
Sharifi et al. | Rapid diagnostics of coronavirus disease 2019 in early stages using nanobiosensors: challenges and opportunities | |
CN109576397B (en) | Human immunodeficiency virus type 1 nucleic acid quantitative detection kit | |
Georgas et al. | ACE2-based capacitance sensor for rapid native SARS-CoV-2 detection in biological fluids and its correlation with real-time PCR | |
Fatin et al. | HIV-1 Tat biosensor: current development and trends for early detection strategies | |
JP2009534033A5 (en) | ||
Khayamian et al. | A label-free graphene-based impedimetric biosensor for real-time tracing of the cytokine storm in blood serum; suitable for screening COVID-19 patients | |
CN110305988A (en) | Pigeon with newcastle disease LAMP-TaqMan detection kit | |
CN102199674A (en) | Enveloped ribonucleic acid (RNA) virus nucleic acid detection reference/standard platform and application method thereof | |
TWI223070B (en) | Method of detecting virus in a test solution using a quartz crystal micro-balance | |
CN101397592A (en) | Biological article for detecting hepatitis b virus covalence closed DNA and use thereof | |
Tsang et al. | Implementation and new insights in molecular diagnostics for HIV infection | |
TW200946905A (en) | Method and device to detect biological molecule using single-dielectrophoresis | |
CN1296693C (en) | Method of utilizing quartz crystal microbalance in detecting virus in sample liquid | |
EP4172633A1 (en) | Methods, compositions, and systems for detecting coronavirus neutralizing antibodies | |
CN111719017A (en) | Novel loop-mediated isothermal amplification detection method and kit for coronary viruses | |
CN104388599A (en) | MASA (multi-analyte suspension array) detection kit for influenza virus H5N1 subtype and H7N9 subtype | |
AU2015413017B2 (en) | Method and identification kit for identifying sensitizing drug for drug allergic reaction | |
US20220404362A1 (en) | Methods and Systems for Detecting SARS-CoV-2 Analytes in Dried Samples | |
Hasan et al. | Plasmonic Grating Based Biosensors for Multiplexed Detection | |
Mukherjee et al. | Biosensors-based approaches for other viral infection detection | |
Mario et al. | SARS-CoV-2 serosurvey in health care workers of the Veneto region | |
Deumić et al. | Biosensor for Rapid Methods for the Detection of Viruses | |
Batista et al. | Diagnostic efficacy of electrochemical biosensor compared to RT-PCR for diagnosis of Covid-19: a systematic review | |
Etienne et al. | COVID-19 Biomarkers and Advanced Sensing Technologies for Point-of-Care (POC) Diagnosis. Bioengineering 2021, 8, 98 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |